New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2014
08:07 EDTRNNRexahn reports Q4 total operating expense $8M
Rexahn’s Q4 cash and investments totaled $19.M vs $14.7M last year. The company said the increase of $4.3M was primarily due to $12.3M from the issuance of common stock and the exercise of stock warrants and options, offset by $8M of net cash used in operating activities.
News For RNN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 13, 2015
17:37 EDTRNNRexahn to present RX-5902, RX-3117, RX-0201 data at 2015 ASCO meeting
Rexahn Pharmaceuticals announced it will present three posters at the 2015 American Society of Clinical Oncology annual meeting, May 29 to June 2. The company will participate in poster sessions on RX-5902, RX-3117, and RX-0201 in combination with everolimus.
May 11, 2015
09:07 EDTRNNRexahn reports Q1 EPS (2c), consensus (3c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use